A detailed history of Srs Capital Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 9,748 shares of PFE stock, worth $260,369. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,748
Previous 9,239 5.51%
Holding current value
$260,369
Previous $258,000 9.3%
% of portfolio
0.03%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$27.7 - $31.39 $14,099 - $15,977
509 Added 5.51%
9,748 $282,000
Q2 2024

Aug 06, 2024

BUY
$25.26 - $29.6 $19,879 - $23,295
787 Added 9.31%
9,239 $258,000
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $3,313 - $3,805
128 Added 1.54%
8,452 $234,000
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $41,259 - $53,591
-1,579 Reduced 15.94%
8,324 $239,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $28,816 - $33,683
-898 Reduced 8.31%
9,903 $328,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $144,841 - $167,577
-4,010 Reduced 27.07%
10,801 $396,000
Q1 2023

May 16, 2023

SELL
$39.39 - $51.28 $6,617 - $8,615
-168 Reduced 1.12%
14,811 $604,000
Q4 2022

Feb 24, 2023

BUY
$41.75 - $54.5 $5,051 - $6,594
121 Added 0.81%
14,979 $767,000
Q3 2022

Nov 03, 2022

BUY
$43.76 - $53.42 $54,262 - $66,240
1,240 Added 9.11%
14,858 $650,000
Q2 2022

Aug 22, 2022

BUY
$46.53 - $55.17 $10,143 - $12,027
218 Added 1.63%
13,618 $714,000
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $9,790 - $12,131
214 Added 1.62%
13,400 $694,000
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $241,102 - $357,393
5,835 Added 79.38%
13,186 $779,000
Q3 2021

Nov 05, 2021

BUY
$39.25 - $50.42 $19,821 - $25,462
505 Added 7.38%
7,351 $316,000
Q2 2021

Aug 02, 2021

SELL
$35.91 - $40.68 $127,839 - $144,820
-3,560 Reduced 34.21%
6,846 $268,000
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $1,907 - $2,425
57 Added 0.55%
10,406 $383,000
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $97,821 - $114,767
3,081 Added 42.39%
10,349 $380,000
Q2 2020

Aug 06, 2020

SELL
$30.12 - $36.54 $97,046 - $117,731
-3,222 Reduced 30.71%
7,268 $238,000
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $276,516 - $395,082
-10,230 Reduced 49.37%
10,490 $342,000
Q4 2019

Feb 07, 2020

SELL
$32.92 - $37.36 $1,218 - $1,382
-37 Reduced 0.18%
20,720 $812,000
Q3 2019

Nov 01, 2019

BUY
$32.49 - $42.13 $1,494 - $1,937
46 Added 0.22%
20,757 $746,000
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $31,322 - $35,167
-847 Reduced 3.93%
20,711 $897,000
Q4 2018

Feb 06, 2019

BUY
$38.47 - $43.86 $194,119 - $221,317
5,046 Added 30.56%
21,558 $941,000
Q3 2018

Nov 06, 2018

SELL
$34.47 - $41.81 $55,979 - $67,899
-1,624 Reduced 8.95%
16,512 $728,000
Q2 2018

Aug 21, 2018

BUY
$32.98 - $35.16 $58,242 - $62,092
1,766 Added 10.79%
18,136 $657,000
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $8,679 - $10,069
-272 Reduced 1.63%
16,370 $580,000
Q4 2017

Feb 15, 2018

BUY
$33.26 - $35.29 $4,922 - $5,222
148 Added 0.9%
16,642 $602,000
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $511,314 - $563,270
16,494
16,494 $588,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.